CYP2E1 overexpression in a transgenic mouse model induced hepatic steatosis and injury [126], whereas application of CYP2E1 antibody inhibited hepatic lipid peroxidation in murine NASH model [127]. Here, CYP2E1 is linked to metabolic dysfunction-associated steatohepatitis.